Searchable abstracts of presentations at key conferences in endocrinology

ea0026p234 | Pituitary | ECE2011

Does GH replacement therapy reduce mortality in adults with GH deficiency? Data from the Dutch National Registry of GH Treatment in adults

van Bunderen C C , van Nieuwpoort I C , Arwert L I , Heymans M W , Franken A A M , Koppeschaar H P F , van der Lely A J , Drent M L

Introduction: Adults with GH deficiency (GHD) have a decreased life expectancy due to cardiovascular diseases (CVD). Recombinant GH treatment has made replacement therapy an option in adults with GHD. Data on long-term efficacy and safety are limited and the implication for life expectancy remains to be established.Methods: The Dutch National Registry of GH Treatment in Adults was founded to gain more insight into long-term efficacy and safety of GH ther...